Guardant Health (GH)
(Delayed Data from NSDQ)
$25.36 USD
-0.88 (-3.35%)
Updated May 17, 2024 04:00 PM ET
After-Market: $25.37 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
GH 25.36 -0.88(-3.35%)
Will GH be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for GH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GH
Stock Market News for May 13, 2024
Compared to Estimates, Guardant Health (GH) Q1 Earnings: A Look at Key Metrics
GH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Guardant Health (GH) Reports Q1 Loss, Tops Revenue Estimates
MannKind (MNKD) Beats Q1 Earnings and Revenue Estimates
Guardant (GH) Gears Up for Q1 Earnings: Here's What to Expect
Other News for GH
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Guardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease Week
Analysts Have Conflicting Sentiments on These Healthcare Companies: AlloVir (ALVR), Guardant Health (GH) and Centessa Pharmaceuticals (CNTA)
Gamehost Inc. Shuts Down Casino Amid Wildfire
Gamehost Announces the Closure of Rivers Casino & Entertainment Centre Due to Area Wildfire